regadenoson
NDC 55150-443, regadenoson, injection, from Eugia US LLC.
- Product NDC
- 55150-443
- Status
- Listed
- Labeler
- Eugia US LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216437
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-443 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-443-01 | 55150044301 | 1 SYRINGE in 1 CARTON (55150-443-01) / 5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/b553eb2d-0c3f-444e-ad4c-282328683110Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55150-443
Use it
Look up 55150-443 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-443 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-443. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.